dc.contributor.author | Larijani, Banafshé | |
dc.contributor.author | Miles, James | |
dc.contributor.author | Ward, Stephen G. | |
dc.contributor.author | Parker, Peter J. | |
dc.date.accessioned | 2021-06-16T11:08:56Z | |
dc.date.available | 2021-06-16T11:08:56Z | |
dc.date.issued | 2021-05-11 | |
dc.identifier.citation | British Journal Of Cancer 124(10) : 1618-1620 (2021) | es_ES |
dc.identifier.issn | 0007-0920 | |
dc.identifier.issn | 1532-1827 | |
dc.identifier.uri | http://hdl.handle.net/10810/51918 | |
dc.description.abstract | Implementation of a quantitative molecular imaging method (iFRET), which determines receptor–ligand interactions, has led to the finding that patients with a low extent of PD-1/PD-L1 interaction in metastatic NSCLC, and malignant melanoma, display significantly worsened overall survival compared to those with a high level of interaction. | es_ES |
dc.description.sponsorship | The original research was supported, in part, by Department of Education, Basque Government-IT1270-19, Elkartek grant (BG18) and the Spanish Ministry grant (MINECO) PROJECTS of EXCELLENCE (BFU2015-65625-P). P.J.P. was supported by a core grant to the Francis Crick Institute, from Cancer Research UK (FC001130), the UK Medical Research Council (FC001130) and the Wellcome Trust (FC001130). | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Springer Nature | es_ES |
dc.relation | info:eu-repo/grantAgreement/MINECO/BFU2015-65625-P | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
dc.subject | quantitative molecular imaging | es_ES |
dc.subject | malignant neoplastic diseases | es_ES |
dc.subject | Immune-checkpoints | es_ES |
dc.title | Quantification of Biomarker Functionality Predicts Patient Outcomes | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.holder | This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) | es_ES |
dc.rights.holder | Atribución 3.0 España | * |
dc.relation.publisherversion | https://www.nature.com/articles/s41416-021-01291-3 | es_ES |
dc.identifier.doi | 10.1038/s41416-021-01291-3 | |
dc.departamentoes | Bioquímica y biología molecular | es_ES |
dc.departamentoeu | Biokimika eta biologia molekularra | es_ES |